Genetics company Genus PIC has entered into a strategic collaboration in China, with Beijing Capital Agribusiness Co. Ltd (BCA), a leading Chinese animal protein genetics business, to research, develop, register and market elite pigs that are resistant to Porcine Reproductive and Respiratory Syndrome.
Bill Christianson, PIC chief operating officer, said: “The combination of Genus’ PRRS resistance technology, elite genetics and breeding know-how along with BCA’s deep understanding of the porcine sector in China and its distribution channels plays to the strengths of each party.
“We are looking forward to rapidly progressing the PRRSv resistance programme in collaboration with BCA and launching this important new product in China.”
The initial phase of the collaboration is expected to take several years and focuses on the research, development and regulatory approval in China of PRRSv resistant pigs. Following regulatory approval and the launch of PRRSv resistant pigs in China, Genus and BCA have agreed that they will work together in a joint venture which will include Genus’s porcine operations in China, PIC China.
Liu Jiantong, general manager and vice chairman of Beijing Capital Agribusiness, said: “We are excited to collaborate with Genus PIC, the world’s leading porcine genetics company, for the registration and launch of PRRSv resistant pigs in China as an important step of a broader partnership.”
